ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000062 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
2,933
Total Value
$947,580.95
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 4, 2026 | Sale | 135 | $319.03 | $43,069.05 | 98,493 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 129 | $320.01 | $41,281.29 | 98,364 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 274 | $320.81 | $87,901.94 | 98,090 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 368 | $321.82 | $118,429.76 | 97,722 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 444 | $323.01 | $143,416.44 | 97,278 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 973 | $323.84 | $315,096.32 | 96,305 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 345 | $324.88 | $112,083.60 | 95,960 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 4, 2026 | Sale | 265 | $325.67 | $86,302.55 | 95,695 | Direct | โ | View Details |